Sirolimus for patients with progressive epithelioid hemangioendothelioma.

Loading...
Thumbnail Image

Embargo End Date

Authors

Smrke, AM
Huang, PH
Jones, RL

Document Type

Journal Article

Date

2020-10-27

Date Accepted

2020-09-12

Abstract

Epithelioid hemangioendothelioma is an ultrarare soft tissue sarcoma with limited literature to guide treatment. The results from a robust retrospective cohort study support the use of sirolimus for patients who have multifocal epithelioid hemangioendothelioma without serosal effusion.

Citation

Cancer, 2020

Source Title

Publisher

WILEY

ISSN

0008-543X

eISSN

1097-0142

Research Team

Molecular and Systems Oncology
Molecular and Systems Oncology

Notes